Growth Metrics

Boston Scientific (BSX) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.19%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 64.73%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.89%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 29.56%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 0.80%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 64.73%
Dec 31, 2025 74.72%
Sep 30, 2025 63.10%
Jun 30, 2025 47.97%
Mar 31, 2025 90.82%
Dec 31, 2024 91.86%
Sep 30, 2024 5.01%
Jun 30, 2024 23.50%
Mar 31, 2024 14.82%
Dec 31, 2023 37.09%
Sep 30, 2023 70.86%
Jun 30, 2023 54.75%
Mar 31, 2023 201.01%
Dec 31, 2022 -68.41%
Sep 30, 2022 11.36%
Jun 30, 2022 16.90%
Mar 31, 2022 -38.84%
Dec 31, 2021 -40.82%
Sep 30, 2021 -2.13%
Jun 30, 2021 -32.37%
Mar 31, 2021 3.26%
Dec 31, 2020 32.37%
Sep 30, 2020 -37.46%
Jun 30, 2020 -44.99%
Mar 31, 2020 -66.40%
Dec 31, 2019 218.23%
Sep 30, 2019 -17.94%
Jun 30, 2019 40.00%
Mar 31, 2019 28.04%
Dec 31, 2018 67.72%
Sep 30, 2018 61.11%
Jun 30, 2018 75.99%
Mar 31, 2018 568.69%
Dec 31, 2017 -27.11%
Sep 30, 2017 87.40%
Jun 30, 2017 231.71%
Mar 31, 2017 29.67%
Dec 31, 2016 4.71%
Sep 30, 2016 262.41%
Jun 30, 2016 -53.15%
Mar 31, 2016 36.99%
Dec 31, 2015 -62.96%
Sep 30, 2015 33.19%
Jun 30, 2015 26.59%
Mar 31, 2015 -26.18%
Dec 31, 2014 -68.62%
Sep 30, 2014 -32.85%
Jun 30, 2014 -69.85%
Mar 31, 2014 42.46%
Dec 31, 2013 -22.94%
Sep 30, 2013 -26.54%
Jun 30, 2013 9.88%
Mar 31, 2013 39.38%
Dec 31, 2012 27.17%
Sep 30, 2012 -91.87%
Jun 30, 2012 -191.01%
Mar 31, 2012 120.30%